APA (7th ed.) Citation

Ladetto, A., Gildea, D. T., & Shenoy, A. (2026). Recurrent Immune Checkpoint Inhibitor Hepatitis With Pembrolizumab Cessation: A Stubborn Case of Delayed-Onset, Steroid-Refractory Hepatotoxicity. ACG Case Reports Journal, 13(4), 1. https://doi.org/10.14309/crj.0000000000002050

Chicago Style (17th ed.) Citation

Ladetto, Allison, Daniel T. Gildea, and Abhishek Shenoy. "Recurrent Immune Checkpoint Inhibitor Hepatitis With Pembrolizumab Cessation: A Stubborn Case of Delayed-Onset, Steroid-Refractory Hepatotoxicity." ACG Case Reports Journal 13, no. 4 (2026): 1. https://doi.org/10.14309/crj.0000000000002050.

MLA (9th ed.) Citation

Ladetto, Allison, et al. "Recurrent Immune Checkpoint Inhibitor Hepatitis With Pembrolizumab Cessation: A Stubborn Case of Delayed-Onset, Steroid-Refractory Hepatotoxicity." ACG Case Reports Journal, vol. 13, no. 4, 2026, p. 1, https://doi.org/10.14309/crj.0000000000002050.